Skip to Main Content

Paper Details

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy.
Open Heart
2
2022
COVID, COVID-19, COVID-19 infections, DCM, HCM, Patients, cardiomyopathy, dilated cardiomyopathy, heart disease, hypertrophic cardiomyopathy, patients
Author NameAffiliation
Rachel BuchanNational Heart and Lung Institute, Imperial College London
Rachel BuchanMRC London Institute of Medical Sciences, Imperial College
Rachel BuchanCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
Abbas DehghanImperial College London School of Public Health
Abbas DehghanImperial College London School of Public Health
Arun John BaksiCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
Angharad M RobertsNational Heart and Lung Institute, Imperial College London
Angharad M RobertsCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
Angharad M RobertsNational Heart and Lung Institute, Imperial College London
Angharad M RobertsCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
Sanjay K PrasadNational Heart and Lung Institute, Imperial College London
Sanjay K PrasadCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
James S WareNational Heart and Lung Institute, Imperial College London
James S WareCardiovascular Research Centre, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust
James S WareMRC London Institute of Medical Sciences, Imperial College
  • 1 - 15

Datasets